OrbiMed’s Illumina ILMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-31,148
| Closed | -$4.22M | – | 120 |
|
|
2023
Q4 | $4.22M | Buy |
+31,148
| New | +$3.59M | 0.08% | 91 |
|
|
2022
Q2 | – | Sell |
-46,363
| Closed | -$15.8M | – | 147 |
|
|
2022
Q1 | $15.8M | Hold |
46,363
| – | – | 0.26% | 78 |
|
|
2021
Q4 | $17.2M | Buy |
+46,363
| New | +$17.6M | 0.22% | 92 |
|
|
2019
Q3 | – | Sell |
-144,126
| Closed | -$51.6M | – | 131 |
|
|
2019
Q2 | $51.6M | Sell |
144,126
-89,538
| -38% | -$28.3M | 0.8% | 38 |
|
|
2019
Q1 | $70.6M | Sell |
233,664
-19,121
| -8% | -$5.58M | 1.09% | 28 |
|
|
2018
Q4 | $73.8M | Sell |
252,785
-22,205
| -8% | -$6.88M | 1.36% | 21 |
|
|
2018
Q3 | $98.2M | Sell |
274,990
-17,476
| -6% | -$5.6M | 1.18% | 25 |
|
|
2018
Q2 | $79.5M | Hold |
292,466
| – | – | 0.95% | 35 |
|
|
2018
Q1 | $67.3M | Sell |
292,466
-45,232
| -13% | -$10.4M | 0.83% | 41 |
|
|
2017
Q4 | $71.8M | Sell |
337,698
-71,960
| -18% | -$14.8M | 0.91% | 37 |
|
|
2017
Q3 | $79.4M | Hold |
409,658
| – | – | 0.76% | 38 |
|
|
2017
Q2 | $69.1M | Buy |
409,658
+78,745
| +24% | +$13.6M | 0.72% | 45 |
|
|
2017
Q1 | $54.9M | Buy |
330,913
+143,611
| +77% | +$22.6M | 0.62% | 49 |
|
|
2016
Q4 | $23.3M | Sell |
187,302
-322,072
| -63% | -$43.4M | 0.3% | 65 |
|
|
2016
Q3 | $90M | Sell |
509,374
-360,520
| -41% | -$57.7M | 1.03% | 35 |
|
|
2016
Q2 | $119M | Sell |
869,894
-55,306
| -6% | -$7.86M | 1.24% | 27 |
|
|
2016
Q1 | $146M | Buy |
925,200
+23,644
| +3% | +$3.61M | 1.54% | 20 |
|
|
2015
Q4 | $168M | Sell |
901,556
-281,672
| -24% | -$45.5M | 1.52% | 21 |
|
|
2015
Q3 | $202M | Hold |
1,183,228
| – | – | 2.04% | 16 |
|
|
2015
Q2 | $251M | Sell |
1,183,228
-53,456
| -4% | -$10.4M | 2.1% | 14 |
|
|
2015
Q1 | $223M | Sell |
1,236,684
-281,261
| -19% | -$53M | 1.91% | 21 |
|
|
2014
Q4 | $273M | Buy |
1,517,945
+137,341
| +10% | +$24.2M | 2.6% | 10 |
|
|
2014
Q3 | $220M | Sell |
1,380,604
-44,204
| -3% | -$7.39M | 2.3% | 13 |
|
|
2014
Q2 | $247M | Buy |
1,424,808
+26,214
| +2% | +$3.91M | 2.91% | 9 |
|
|
2014
Q1 | $202M | Sell |
1,398,594
-242,916
| -15% | -$35.7M | 2.49% | 10 |
|
|
2013
Q4 | $177M | Buy |
1,641,510
+3,084
| +0.2% | +$282K | 2.6% | 13 |
|
|
2013
Q3 | $129M | Sell |
1,638,426
-59,624
| -4% | -$4.56M | 2.3% | 14 |
|
|
2013
Q2 | $124M | Buy |
+1,698,050
| New | +$109M | 2.62% | 10 |
|
Other funds holding ILMN
OrbiMed's ILMN Position: Q1 2024 in Review
OrbiMed sold out of Illumina (ILMN) in Q1 2024, closing a stake of 31,148 shares — an estimated $4.22M sold.
OrbiMed first reported a position in ILMN in Q2 2013 and held it in 28 quarters. The position peaked at $273M in Q4 2014. 795 funds tracked by Wall St. Rank hold ILMN as of Q1 2024.
- OrbiMed reported no remaining Illumina position as of Q1 2024 after selling out during the quarter.
- OrbiMed sold 31,148 Illumina shares in Q1 2024, an estimated $4.22M.
- OrbiMed first reported a position in Illumina in Q2 2013 and held it in 28 quarters.
- OrbiMed's Illumina position peaked at $273M in Q4 2014.
- 795 funds tracked by Wall St. Rank held Illumina as of Q1 2024.
Based on OrbiMed's 13F filing for Q1 2024, filed 15 May 2024.